Regeneron stock (NASDAQ: REGN) Jumps Up. Is it a Buy?
One of the most talked-about stocks this week is Regeneron Pharmaceuticals Inc (NASDAQ: REGN) due to its COVID treatment. Biotech giant Regeneron claims that its antibody mix reduces the chance of COVID-19 infective. It has been claimed for nearly 82% […]
Regeneron stock (NASDAQ: REGN) Jumps Up. Is it a Buy? Read More »
